Rehabilitation of patients with cancer of the respiratory system
Journal Title: OncoReview - Year 2012, Vol 2, Issue 4
Abstract
Many patients with lung cancer have concomitant chronic obstructive pulmonary disease and heart diseases. The planned anticancer therapy should be individualized in relationship of patient’s cardiac and pulmonary condition. Pulmonary rehabilitation is based on evidence, its main aim is to improve the quality of life by increasing physical fitness and optimal pattern of ventilation. It may prevent complications such as hypoxemia, respiratory infections, symptoms related to immobilization during hospitalization. Rehabilitation can be recommended both before and after lung resection. The most effective way to prevent post-operative complications is early respiratory physiotherapy before and after surgery. Properly rehabilitation can also be very useful in patients treated with palliative radio- or chemotherapy. The article is a summary of the available results and efficiency of the rehabilitation in patients with lung cancer.
Authors and Affiliations
Oliwia Głogowska, Sebastian Szmit, Maciej Głogowski
Keywords
Related Articles
- EP ID EP53179
- DOI -
- Views 237
- Downloads 0
Leczenie nadpłytkowości samoistnej w ciąży - doświadczenia własne ośrodka
Nadpłytkowość samoistna (ET) jest przewlekłym nowotworem mieloproliferacyjnym dotyczącym głównie linii megakariocytów, przebiegającym ze zwiększoną ponad 450 000/ul liczbą płytek krwi. Nadpłytkowość występuje przede wszy...
Kontrola działań niepożądanych podczas terapii ewerolimusem – doświadczenia własne ośrodka
Założenia: Rak nerkowokomórkowy (RCC, renal cell carcinoma) stanowi 80–85% wszystkich nowotworów złośliwych nerki. Ewerolimus należy do grupy leków selektywnie hamujących kinazę mTOR, ostatnio został zarejestrowany do le...
Recurrent invasive pulmonary aspergillosis or breakthrough fungal infection in a child after haploidentical hematopoietic stem cell transplantation
Invasive fungal infections (IFI) are devastating and life threatening infections affecting especially immunocompromised patients. We report on a case of a 14-year-old boy with myelodysplastic syndrome (MDS), after haplo...
Pazopanib - dilemmas in kidney cancer treatment
Progress in metastatic renal cell carcinoma treatment is generally based on new registered drugs. This brings improvement of results but it also needs the choice of proper drug. The decision is especially important in in...
Chemotherapy in gastroenteropancreatic neuroendocrine neoplasm (GEP-NEN)
Approximately two-thirds of malignant GEP-NENs are metastatic at discovery. Chemotherapy with platinum and etoposide is a standard therapy for poorly differentiated GEP-NEC. For well-differentiated pancreatic GEP-NEN ass...